Shares of Becton Dickinson & Co. BDX slid 6.43% to $207.34 Friday, on what proved to be an all-around rough trading session ...

Becton Dickinson (NYSE:BDX) is in talks with rivals including Thermo Fisher (TMO) and Danaher (DHR) over plans to divest its ...

Generation Investment Management, an investment management firm, released its “Global Equity Strategy” fourth quarter 2024 ...

Becton, Dickinson and Co. also reported slightly higher pay for the device developer and manufacturer's median worker in ...

Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.

In February the company had announced its plan to separate the unit, which consists of biosciences and diagnostic solutions, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Becton Dickinson (BDX) announced the first patient treated in an investigational device exemption clinical trial intended to advance BD’s ...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” ...

Recent high-profile financial activities involve Andreessen Horowitz's potential investment in TikTok, EU fines for a vehicle ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment ...